• Filter By:
• Specialty
• Source
• Condition
• Cancer
• Infectious Disease
• Drug
• Training
• Management
• Procedure
• Therapy
• Vaccine
• Nutrition
• Country

Comprehensive care of adults with respiratory diseases must include vaccines
Vaccines are among the most effective tools we have to improve and save lives, but only if they are administered to eligible patients. In this issue, Naeger et al1 highlight the major opportunities that the health care community has to achieve high adult vaccination rates. These vaccines include those for prevention of coronavirus disease 2019 (COVID-19), pneumococcal, and influenza, diseases that respiratory health professionals are most aware of, plus pertussis (in Tdap), herpes zoster (HZ, shingles), and as of May 3, 2023, respiratory syncytial viral, for which adults with asthma and chronic obstructive pulmonary diseas...
Source: Annals of Allergy, Asthma and Immunology - September 1, 2023 Category: Allergy & Immunology Authors: Barbara P. Yawn, Dennis Williams, Gregory Poland Tags: Editorial Source Type: research

Early detection of x-linked moesin-associated immune deficiency on newborn screening
X-Linked Moesin-Associated Immune Deficiency (X-MAID) is a combined T and B cell immunodeficiency that can lead to recurrent bacterial infections, increased susceptibility to varicella zoster virus, and decreased immune response to vaccine antigens. Due to variability of X-MAID severity, cases have been diagnosed in adulthood as well as through state newborn screening.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2022 Category: Allergy & Immunology Authors: S. Latshaw, E. Conboy, K. Overholt, M. Kim, J. Jin Tags: M229 Source Type: research

P158 one in a million: anaphylaxis to varivax ® in a non-immune healthcare worker
We report a rare case of anaphylaxis following Varivax ® administration in a HCW with negative varicella zoster virus (VZV) IgG titers.
Source: Annals of Allergy, Asthma and Immunology - November 1, 2020 Category: Allergy & Immunology Authors: C. Foster, E. Shohfi, M. Petersen Source Type: research

From the Pages of Allergy Watch
For this month ’s issue of Annals, which focuses on vaccines, I’ve selected 3 article summaries from recent Allergy Watch that reviewed studies on various aspects of vaccines. The first reports data from the pivotal study showing the improved efficacy of the new recombinant subunit herpes zoster vaccine. The n ext review describes a report of a unique vaccine for cats that induces IgG blocking antibodies for Fel d 1. The last review shows discrepant results of pneumococcal titers from different labs.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

From the pages of AllergyWatch
For this month's issue of Annals, which focuses on vaccines, there are 3 article summaries from recent AllergyWatch columns that reviewed studies on various aspects of vaccines. The first reports data from a pivotal study on the improved efficacy of the new recombinant subunit herpes zoster vaccine. The second review describes a report of a unique vaccine for cats that induces immunoglobulin G –blocking antibodies for Fel d 1. The third review reports discrepant results of pneumococcal titers from different laboratories.
Source: Annals of Allergy, Asthma and Immunology - April 23, 2020 Category: Allergy & Immunology Authors: David A. Khan, Gerald B. Lee, Stanley M. Fineman Tags: Special Series Source Type: research

Recombinant zoster vaccine administration in an allergy/immunology practice: a medical and economic case
Thousands of US adults are killed by vaccine-preventable diseases each year,1 however, adult immunization rates in the US remain low, ranging from 8-64%.2 Increasing vaccination rates, and therefore preventing disease, requires an establishment of value by healthcare professionals and improved access to vaccinations.1 Allergists/immunologists should consider implementing routine vaccine administration for adolescents and adults into their practices. More than half of outpatient visits in the US are to specialists.
Source: Annals of Allergy, Asthma and Immunology - February 19, 2020 Category: Allergy & Immunology Authors: Hannah G. Russell, Mike S. Tankersley Tags: Letters Source Type: research

Recombinant zoster vaccine administration in an allergy/immunology practice: a medical and economic case.
PMID: 32088321 [PubMed - as supplied by publisher]
Source: Annals of Allergy, Asthma and Immunology - February 19, 2020 Category: Allergy & Immunology Authors: Russell HG, Tankersley MS Tags: Ann Allergy Asthma Immunol Source Type: research

Recombinant zoster vaccine administration in an allergy and immunology practice
Thousands of US adults are killed by vaccine-preventable diseases each year1; however, the adult immunization rates in the United States remain low, ranging from 8% to 64%.2 Increasing vaccination rates, and therefore preventing diseases, requires an establishment of value by health care professionals and improved access to vaccines.1 Allergists/immunologists should consider implementing routine vaccine administration for adolescents and adults into their practices. More than half of outpatient visits in the United States are to specialists.
Source: Annals of Allergy, Asthma and Immunology - February 19, 2020 Category: Allergy & Immunology Authors: Hannah G. Russell, Mike S. Tankersley Tags: Letters Source Type: research

P235 treatment patterns of influenza and zoster vaccinations in patients prescribed mepolizumab
This study examines the prevalence and patterns of influenza and herpes zoster vaccination among patients treated with mepolizumab in the real-world.
Source: Annals of Allergy, Asthma and Immunology - October 31, 2019 Category: Allergy & Immunology Authors: J. Llanos, J. Mao, M. Bogart, J. Silver, C. Blauer-Peterson, E. Hulbert, B. Hahn Source Type: research

Induction of Immune Response and Protective Immunity by a Local Isolated Varicella Virus in Animal Model: A Future Candidates for Vaccine Production.
Abstract Preparation of the indigenous varicella zoster vaccine could significantly reduce the disease burden of varicella zoster virus especially in immunosuppressed children. To achieve this goal, the varicella zoster virus was isolated from an 8 years boy infected with chicken pox. The virus was cultivated in sensitive cell line and determined varicella zoster. The adaptation and attenuation of virus was carried out after several passages in MRC-5 cell culture, Primary Guinea pig embryo fibroblast cell culture and again switching in MRC-5 cell culture. The challenged of vaccine dose was found 3LogCCID50. Follow...
Source: Iranian Journal of Allergy, Asthma and Immunology - December 31, 2018 Category: Allergy & Immunology Authors: Esna-Ashari F, Sabahi F, Ravanshad M, Mohammadi A Tags: Iran J Allergy Asthma Immunol Source Type: research

Shingles Risk 70% Higher for Adults With AsthmaShingles Risk 70% Higher for Adults With Asthma
Researchers suggest considering zoster vaccine for those aged 50 years and older with asthma. Their findings build on their previous work showing a link between childhood asthma and shingles. Medscape Medical News
Source: Medscape Allergy Headlines - January 6, 2016 Category: Allergy & Immunology Tags: Allergy & Clinical Immunology News Source Type: news